Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Adam Searleman

    TitleResident Physician
    SchoolUniversity of California, San Diego
    Address200 W. Arbor Drive #8756
    CA San Diego 92103
    vCardDownload vCard

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Lu X, Ma Y, Chang EY, He Q, Searleman A, von Drygalski A, Du J. Simultaneous quantitative susceptibility mapping (QSM) and R2* for high iron concentration quantification with 3D ultrashort echo time sequences: An echo dependence study. Magn Reson Med. 2018 Jan 04. PMID: 29314215.
        View in: PubMed
      2. Kavuri SM, Jain N, Galimi F, Cottino F, Leto SM, Migliardi G, Searleman A, Shen W, Monsey J, Trusolino L, Jacobs SA, Bertotti A, Bose R. HER2 activating mutations are targets for colorectal cancer treatment. Cancer Discov. 2015 Aug; 5(8):832-41. PMID: 26243863; PMCID: PMC4527087.
      3. Kumar RD, Searleman A, Swamidass SJ, Griffith OL, Bose R. Statistically identifying tumor suppressors and oncogenes from pan-cancer genome-sequencing data. Bioinformatics. 2015 Nov 15; 31(22):3561-8. PMID: 26209800; PMCID: PMC4757952 [Available on 11/15/16].
      4. Takeda S, Sasagawa S, Oyama T, Searleman A, Westergard TD, Cheng EH, Hsieh JJ. Taspase1-dependent TFIIA cleavage coordinates head morphogenesis by limiting Cdkn2a locus transcription. J Clin Invest. 2015 Mar 02; 125(3):1203-14. PMID: 25664857; PMCID: PMC4362222.
      5. Searleman A, Iliuk AB, Collier TS, Chodosh LA, Tao WA, Bose R. Tissue phosphoproteomics with PolyMAC identifies potential therapeutic targets in a transgenic mouse model of HER2 positive breast cancer. Electrophoresis. 2014 Dec; 35(24):3463-9. PMID: 24723360; PMCID: PMC4193948.
      6. Bose R, Kavuri SM, Searleman A, Shen W, Shen D, Koboldt DC, Monsey J, Goel N, Aronson AB, Li S, Ma CX, Ding L, Mardis ER, Ellis MJ. Activating HER2 mutations in HER2 gene amplification negative breast cancer. Cancer Discov. 2013 Feb; 3(2):224-37. PMID: 23220880; PMCID: PMC3570596.
      7. Chen DY, Lee Y, Van Tine BA, Searleman A, Westergard TD, Liu H, Tu HC, Takeda S, Dong Y, Piwnica-Worms DR, Oh KJ, Korsmeyer SJ, Hermone A, Gussio R, Shoemaker RH, Cheng EH, Hsieh JJ. A pharmacologic inhibitor of the protease Taspase1 effectively inhibits breast and brain tumor growth. Cancer Res. 2012 Feb 01; 72(3):736-46. PMID: 22166309; PMCID: PMC3325786.
      8. Avidan MS, Searleman A, Storandt M, Barnett K, Vannucci A, Saager L, Xiong C, Grant EA, Kaiser D, Morris JC, Evers AS. Long-term cognitive decline in older subjects was not attributable to noncardiac surgery or major illness. Anesthesiology. 2009 Nov; 111(5):964-70. PMID: 19786858; PMCID: PMC2783989.
      9. Finkel KJ, Searleman A, Tymkew H, Tanaka CY, Saager L, Safer-Zadeh E, Bottros M, Selvidge JA, Jacobsohn E, Pulley D, Duntley S, Becker C, Avidan MS. Prevalence of undiagnosed obstructive sleep apnea among adult surgical patients in an academic medical center. Sleep Med. 2009 Aug; 10(7):753-8. PMID: 19186102.
        View in: PubMed
      10. Avidan MS, Zhang L, Burnside BA, Finkel KJ, Searleman A, Selvidge JA, Saager L, Turner MS, Rao S, Bottros M, Hantler C, Jacobsohn E, Evers AS. Anesthesia awareness and the bispectral index. N Engl J Med. 2008 Mar 13; 358(11):1097-108. PMID: 18337600.
        View in: PubMed
      11. Searleman A, Fugagli AK. Suspected autoimmune disorders and left-handedness: evidence from individuals with diabetes. Crohn's disease and ulcerative colitis. Neuropsychologia. 1987; 25(2):367-74. PMID: 3601042.
        View in: PubMed
      Adam's Networks
      Derived automatically from this person's publications.
      People in Profiles who have published with this person.
      Similar People
      People who share similar concepts with this person.
      Same Department